Guardion Health Sciences, Inc. (GHSI)
| Previous Close | 3.2900 |
| Open | 3.2200 |
| Bid | 3.2300 x 45100 |
| Ask | 3.2900 x 0 |
| Day's Range | 3.2200 - 3.2200 |
| 52 Week Range | 3.0400 - 18.0000 |
| Volume | |
| Avg. Volume | 127,067 |
| Market Cap | 4.347M |
| Beta (5Y Monthly) | 0.71 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.1100 |
| Earnings Date | Nov 11, 2024 - Nov 15, 2024 |
| Forward Dividend & Yield | 20.00 (174.67%) |
| Ex-Dividend Date | Sep 24, 2024 |
| 1y Target Est | N/A |
GlobeNewswireGuardion Health Sciences Announces Filing of Certificate of Dissolution
HOUSTON, TEXAS, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”) today announced that it has filed a certificate of dissolution with the Secretary of State of the State of Delaware, which became effective upon filing on October 30, 2024 (the “Effective Date”). The filing of the certificate was made pursuant to the terms of the Company’s Plan of Liquidation and Dissolution (the “Plan”) approved by stockholders at the Company’s special m
TipRanksGuardion Health Sciences Announces Delisting and New Interim CEO
Guardion Health Sciences ( (GHSI) ) has issued an announcement. Guardion Health Sciences, Inc. has initiated a significant corporate shakeup, announcing both the delisting of its common stock from the Nasdaq Capital Market and the appointment of Mark Goldstone as the Interim President and CEO, effective October 18, 2024. This move comes as part of a larger dissolution and liquidation plan following the sale of its Viactiv® brand. Goldstone, with over two decades of healthcare industry experience
